Accessibility Menu
Synergy Chc logo

Synergy Chc(NASDAQ) SNYR

Market Cap$2.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-99%
5 Year-85%
1 Year-95%
1 Month-20%
$0.17
-1.49%
-0.00Today
Synergy Chc last closing stock price
MetricPriceDate
Last closeUSD 0.172026-08-10
Synergy Chc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.87%USD 0.182026-08-03
1 month-19.97%USD 0.212026-07-10
3 month-46.59%USD 0.312026-05-12
Year to date-91.12%USD 1.862025-12-31
1 year-95.34%USD 3.542025-08-08
3 year+38.74%USD 0.122023-07-25
5 year-84.57%USD 1.072021-08-11
Since inception-99.31%USD 23.802014-04-29

Synergy Chc Financials at a Glance

Market Cap

$2.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$27.70M

Net Income (TTM)

-$15.79M

EPS (TTM)

-$1.36

P/E Ratio

-0.12

Dividend

$0.00

Beta (Volatility)

-37.82 (Low)

Price

$0.17

Volume

70

Open

$0.17

Previous Close

$0.17

Daily Range

$0.16 - $0.17

52-Week Range

$0.16 - $3.99

Estimated Earnings Date

Aug 13, 2026

SNYR News

Foolcom-Featured.png

Synergy Chc EPS Jumps 86 Percent in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Synergy Chc

Synergy CHC makes health, beauty, and lifestyle products for everyday consumers. Its supplements and skincare help people manage wellness and appearance. The company sells mainly in the U.S. Canada, and the U.K.

Products and Services

  • Nutritional Supplements (82.8% of revenue in Q2 2025): FOCUSfactor supports brain health for adults seeking cognitive benefits.
  • Lifestyle Products: Flat Tummy offers teas, shakes, and accessories for women focused on wellness.
  • Skincare: Hand MD provides anti-aging creams and hand sanitizers for consumers wanting skin care solutions.
  • License Revenue (17.2% of revenue in Q2 2025): Income from licensing brands to partners in select foreign markets.

Growth and Expansion

  • Launched FOCUSfactor ready-to-drink beverage in 2025 to expand product lines.
  • Entered Mexico market by forming Synergy CHC Mexico in May 2025.
  • Signed new license agreements in 2025 to grow international revenue streams.
  • Refinanced debt and restructured capital in 2025 to support future growth.

What Makes Synergy CHC Stand Out

The company uses a multi-channel approach, selling through both retail stores and online. Synergy CHC’s focus on licensing and international expansion diversifies its revenue sources.

Five Things You Need to Know

  • Revenue was $8.13 million in Q2 2025, up 1.4% year-on-year.
  • Gross profit margin reached 77% in Q2 2025, up from 69% in Q2 2024.
  • Net income was $1.47 million in Q2 2025, up 124.9% year-on-year.
  • Three customers made up 80% of net revenue in H1 2025.

Bottom Line

Synergy CHC has evolved by expanding its product lines and entering new markets. Its business model relies on brand development, licensing, and multi-channel sales.

AI Generated • Apr 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

28

CEO

Jack Ross

Website

www.synergychc.com

Headquarters

Westbrook, ME 04092, US

SNYR Financials

Key Financial Metrics (TTM)

Gross Margin

65.13%

Operating Margin

-15.57%

Net Income Margin

-56.98%

Return on Equity

91.30%

Return on Capital

-48.77%

Return on Assets

-244.31%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

14.90M

Volume

70

Avg. Volume

2.40M

Financials (TTM)

Gross Profit

$18.04M

Operating Income

-$4.31M

EBITDA

-$8.69M

Operating Cash Flow

-$3.81M

Capital Expenditure

$0.00

Free Cash Flow

-$3.81M

Cash & ST Invst.

$292.12K

Total Debt

$27.75M

Synergy Chc Performance Analysis

Synergy Chc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 38,410,674N/A
20232023-12-31USD 42,777,63311.4%
20242024-12-31USD 34,834,243-18.6%
20252025-12-31USD 30,380,809-12.8%
Synergy Chc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-0.4%
Q32025-09-30-1.5%
Q42025-12-31-24.3%
Q12026-03-31-9.4%
Synergy Chc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -45.46N/A
20232023-12-31USD 8.83N/A
20242024-12-31USD 0.25-97.2%
20252025-12-31USD -1.27N/A
Synergy Chc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3070.0%
Q32025-09-30-92.7%
Q42025-12-31-12600.0%
Q12026-03-3185.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.49M

-32.8%

Gross Profit

$3.94M

-36.1%

Gross Margin

71.69%

N/A

Market Cap

$2.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$87.86K

N/A

Employees

28

N/A

Net Income

-$2.57M

-393.2%

EBITDA

-$537.17K

-126.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$292.12K

+64.2%

Total Debt

$27.75M

-1.3%

Accounts Receivable

$1.27M

-88.1%

Inventory

$3.38M

+44.1%

Long Term Debt

$25.02M

+7.7%

Short Term Debt

$2.73M

-44.1%

Return on Assets

-2.44%

N/A

Return on Invested Capital

11.14%

N/A

Free Cash Flow

-$2.04M

-148.5%

Operating Cash Flow

-$2.04M

-148.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLSDClearside Biomedical, Inc.
$0.41+0.00%
PRPHProPhase Labs, Inc.
$0.05+25.00%
PCSAProcessa Pharmaceuticals, Inc.
$2.61+1.56%
NXLNexalin Technology, Inc.
$0.34-3.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$97.52-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.80-0.01%
NVDANvidia
$217.55-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.73+0.01%

Questions About SNYR

What is the current price of Synergy Chc?

Synergy Chc is trading at $0.17 per share.

What is the 52-week range for Synergy Chc?

Over the past 52 weeks, Synergy Chc has traded between $0.16 and $3.99.

How much debt does Synergy Chc have?

As of the most recent reporting period, Synergy Chc reported total debt of $27.75M.

How much cash does Synergy Chc have on hand?

Synergy Chc reported $392.12K in cash and cash equivalents in its most recent financial results.

What is Synergy Chc’s dividend yield?

Synergy Chc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services